To prove that the diminished Smad7 expression seen in Cay 10591-treated IBD LPMC was dependent on the ubiquitination-mediated proteasomal degradation, IBD LPMC were pre-incubated with proteasome inhibitors and then treated with Cay 10591. Here, SMAD7 is linked to inflammatory bowel disease.